PepGen logo

PepGen

2 followers
‌

Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.

Industries

Employees

11-50

Links


Org chart

James McArthur
President & CEO
Collapse
Emiko Bryant
SVP, HR & Administration
Paul Streck
Executive Vice President Research And Development
Christine W.
Senior Human Resources Manager
Maryanne Senn
Senior Director, HRBP
Kasra Kasraian
Chief Technical Officer
Joseph Vittiglio
Chief Business & Legal Officer
Jaya Goyal
EVP, Research & Preclinical Development

Board & advisors

Laurie Keating
Chair of the Board of Directors
Habib Joseph Dable
Non-Executive Director
Chris Ashton
Non-Executive Director
Josh Resnick
Non-Executive Director
Matthew Wood
Scientific Advisor
John Watts
Scientific Advisor
Beth McNally
Scientific Advisor
Art Krieg
Scientific Advisor
Brenda Wong
Scientific Advisor
Charles Thornton
Scientific Advisor
Heidi Henson
Non-Executive Director
John W. Day
Scientific Advisor